Detalles de la búsqueda
1.
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults.
J Infect Dis
; 222(10): 1681-1691, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32687161
2.
Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.
Proc Natl Acad Sci U S A
; 114(9): 2425-2430, 2017 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193898
3.
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.
J Infect Dis
; 214(5): 762-71, 2016 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27296848
4.
A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
Malar J
; 15(1): 543, 2016 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825382
5.
The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity.
Malar J
; 15: 301, 2016 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27245446
6.
Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
BMC Immunol
; 16: 63, 2015 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26493839
7.
The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants.
Malar J
; 14: 72, 2015 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25885325
8.
Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes.
Malar J
; 13: 263, 2014 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25007730
9.
A candidate antibody drug for prevention of malaria.
Nat Med
; 30(1): 117-129, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38167935
10.
A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults.
J Clin Immunol
; 33(8): 1360-75, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24142232
11.
A tool for evaluating heterogeneity in avidity of polyclonal antibodies.
Front Immunol
; 14: 1049673, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36875126
12.
Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.
Malar J
; 11: 384, 2012 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23173602
13.
Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.
Lancet Infect Dis
; 22(9): 1329-1342, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35753316
14.
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.
J Infect Dis
; 202(7): 1076-87, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20735271
15.
Whole blood can be used as an alternative to isolated peripheral blood mononuclear cells to measure in vitro specific T-cell responses in human samples.
J Immunol Methods
; 492: 112940, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33493551
16.
Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies.
Med
; 2(11): 1269-1286.e9, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35590199
17.
Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection.
NPJ Vaccines
; 6(1): 110, 2021 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462438
18.
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection Trials.
Front Big Data
; 4: 672460, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212134
19.
A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses.
Elife
; 92020 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342859
20.
Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination.
Vaccine
; 38(7): 1678-1689, 2020 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932137